Cellectis (CLLS) Other Accumulated Expenses (2014 - 2026)

Cellectis' Other Accumulated Expenses history runs 13 years deep, the most recent figure standing at $8.2 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 25.21% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $8.2 million (up 25.21% YoY), while the FY2025 annual figure was $12.3 million, up 22.23% from the prior year.
• Other Accumulated Expenses was $8.2 million for Q1 2026 at Cellectis, down from $12.3 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $13.2 million in Q4 2022 to a low of $6.1 million in Q1 2023.
• Historically, Other Accumulated Expenses has averaged $9.6 million across 5 years, with a median of $9.9 million in 2025.
• The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses sank 34.06% in 2023, then climbed 25.21% in 2026.
• A 5-year view of Other Accumulated Expenses shows it stood at $13.2 million in 2022, then dropped by 22.46% to $10.2 million in 2023, then fell by 1.19% to $10.1 million in 2024, then increased by 22.23% to $12.3 million in 2025, then slumped by 33.4% to $8.2 million in 2026.
• The last three Other Accumulated Expenses figures came in at $8.2 million (Q1 2026), $12.3 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.